Install
Stay informed on the latest biopharmaceutical news, trends, and developments in Asia Pacific with BioPharma APAC. BioPharma Asia ( APAC ) provides in-depth analysis, insights, and expert commentary on drug development, regulatory updates, and industry partnerships in the region.
- 301articles · 90d
- 2+ day agolatest article
- Jun 15, 2026earliest in window
- 93%with images
- 274avg words
- Medical 185
- Health & Wellness 156
- Business & Industrial 121
- Economy, Business & Finance 121
- Health 93
- Science & Technology 81
- Science & Nature 63
- Finance & Business 32
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Kelun-Biotech’s Twice-Yearly Asthma Candidate SKB378 Advances into Phase III
3+ day, 7+ hour ago (143+ words) 10 September 2026 | Thursday | News Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company") announced that its partner, Windward Bio, has reported positive interim results from the Phase 2 portion of the POLARIS-1 clinical trial, which evaluates twice-yearly dosing of SKB378/WIN378 in asthma. The…...
Convergen Raises $15M Seed+ to Accelerate Targeted Protein Degradation Therapies
1+ week, 4+ day ago (60+ words) 02 September 2026 | Wednesday | News The proceeds will be used to further advance Convergen's proprietary degrader platform and accelerate its pipeline for neurodegenerative disorders and other protein aggregation diseases. Two Chairs, 11,000 Kilometres Apart: The Human Cost of Asia’s Plasma Dependence China Plus…...
Thermo Fisher Strengthens China Focus as Biopharma Innovation Gains Global Momentum
1+ week, 5+ day ago (344+ words) 01 September 2026 | Tuesday | News Thermo Fisher Scientific is reinforcing its commitment to China as the country emerges as an increasingly important source of global biopharmaceutical innovation, with Chairman and CEO Marc Casper highlighting opportunities to support Chinese drug developers across discovery,…...
The Biological Age Business
2+ week, 3+ day ago (577+ words) 26 August 2026 | Wednesday | Analysis Figure 1. Regulatory classification of biological age test categories against market, as at 17 August 2026. Cells record the published instrument in force, not enforcement practice. Anyone with a view has until that Friday evening to put it on the…...
Biocon Partners with Innomar Strategies to Strengthen Canada Supply Chain
2+ week, 5+ day ago (142+ words) 24 August 2026 | Monday | News Biocon has partnered with Innomar Strategies, a healthcare services and logistics company, to strengthen its pharmaceutical supply chain and distribution network across Canada. Under the collaboration, Innomar Strategies will serve as Biocon’s exclusive third-party logistics (3PL) provider in…...
South Korea’s Rznomics Joins Lilly Gateway Labs in US to Accelerate RNA Gene Therapies
2+ week, 5+ day ago (159+ words) 24 August 2026 | Monday | News Rznomics Inc.(KOSDAQ: 476830), a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced that it is joining Lilly Gateway Labs (LGL) in San Diego, California. Through its entry into Lilly Gateway Labs, Rznomics plans to…...
Lōkahi Therapeutics Expands ai² Futures Lab Collaboration with University of Georgia
2+ week, 6+ day ago (133+ words) 24 August 2026 | Monday | News During its first year, the ai² Futures Lab™ engaged 64 students and identified more than 45 potential acquisition assets. Several of these advanced into active pipeline discussions, demonstrating how the program expands Lōkahi’s sourcing reach and analytical capacity while supporting…...
Merck Expands Singapore BioReliance Lab with First Cell Line Characterisation and GMP NGS Capabilities in Asia Pacific
1+ mon, 1+ day ago (175+ words) BioPharma APAC - Merck Expands Singapore BioReliance Lab with First Cell Line Characterisation and GMP NGS Capabilities in Asia Pacific 11 August 2026 | Tuesday | News - Expansion adds first BioReliance® Cell Line Characterization and GMP Next-Generation Sequencing in Asia Pacific - Enhanced testing capabilities to…...
Porton Advanced Secures China Commercial Manufacturing Licence for Cell and Gene Therapy CDMO Services
1+ mon, 6+ day ago (282+ words) 07 August 2026 | Friday | News Under China's drug manufacturing license administration regulations, a Class C license permits a company to engage in contract manufacturing on behalf of a Marketing Authorization Holder (MAH). This license is a mandatory legal requirement for entities operating…...
Biocon Launches Interchangeable YESAFILI Biosimilar to EYLEA in the U.S.
1+ mon, 1+ week ago (156+ words) 06 August 2026 | Thursday | News This marks an important step in expanding the global availability of biosimilar aflibercept for patients with eye conditions. An estimated 19.8 million Americans are living with age-related macular degeneration (AMD) while U.S.1 sales of aflibercept reached approximately $5.89 billion in…...